{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:02:12Z","timestamp":1759881732510,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.oftal.2019.07.013","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T13:16:16Z","timestamp":1569503776000},"page":"521-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Povidona yodada. \u00bfUn nuevo paradigma en el tratamiento de la conjuntivitis adenov\u00edrica?"],"prefix":"10.1016","volume":"94","author":[{"given":"J.","family":"Gonz\u00e1lez-Mart\u00edn-Moro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zarallo-Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2019.07.013_bib0070","first-page":"108","article-title":"Adenoviral keratoconjunctivitis: An update","volume":"88","author":"Gonzalez-Lopez","year":"2013","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.oftal.2019.07.013_bib0075","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: A clinical prospective controlled randomized study","volume":"95","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oftal.2019.07.013_bib0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/jop.2011.0082","article-title":"Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: A pilot study","volume":"28","author":"Trinavarat","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.oftal.2019.07.013_bib0085","first-page":"434","article-title":"Povidone-iodine as an ophthalmic antiseptic","volume":"17","author":"Kiffney","year":"1966","journal-title":"Surg Forum"},{"key":"10.1016\/j.oftal.2019.07.013_bib0090","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJM199503023320903","article-title":"A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum","volume":"332","author":"Isenberg","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oftal.2019.07.013_bib0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2006-926633","article-title":"Povidone-iodine for treatment of adenoviral conjunctivitis: An in vitro study [Article in German]","volume":"223","author":"Monnerat","year":"2006","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.oftal.2019.07.013_bib0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1167\/iovs.10-5944","article-title":"Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis","volume":"52","author":"Clement","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oftal.2019.07.013_bib0105","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12325-009-0062-1","article-title":"A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis","volume":"26","author":"Pelletier","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.oftal.2019.07.013_bib0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/15569527.2014.888077","article-title":"Povidone iodine in the treatment of adenoviral conjunctivitis in infants","volume":"34","author":"Ozen Tunay","year":"2015","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.oftal.2019.07.013_bib0115","first-page":"968","article-title":"The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis","volume":"66","author":"Yazar","year":"2016","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.oftal.2019.07.013_bib0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICU.0000000000000437","article-title":"The use of povidone-iodine in ophthalmology","volume":"29","author":"Grzybowski","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oftal.2019.07.013_bib0125","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3109\/02713683.2014.964419","article-title":"Dexamethasone\/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial","volume":"40","author":"Pinto","year":"2015","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oftal.2019.07.013_bib0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/OPTH.S191275","article-title":"A randomized controlled trial of povidone-iodine\/dexamethasone ophthalmic suspension for acute viral conjunctivitis","volume":"13","author":"Pepose","year":"2019","journal-title":"Clin Ophthalmol"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669119302370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669119302370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:43:43Z","timestamp":1759794223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365669119302370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0365669119302370"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2019.07.013","relation":{},"ISSN":["0365-6691"],"issn-type":[{"type":"print","value":"0365-6691"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Povidona yodada. \u00bfUn nuevo paradigma en el tratamiento de la conjuntivitis adenov\u00edrica?","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2019.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}